Ascendis Pharma ADR (ASND) Stock Price, Quote & News

Company Profile

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clini...

Industry: Biotechnology

Sector: Healthcare

Phone: 45 70 22 22 44

Website: ascendispharma.com

Address:

Tuborg Boulevard 12, Hellerup, Denmark

JamesTaulman Jul. 15 at 3:23 AM

$ASND – TUE: A Break Below the Recent Low of $262.00 Would Be a 2nd Sell Signal 9:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/tue-7-14-asnd-a-break-below-the-recent-low-of-262-00-would-be-a-2nd-sell-signal/

0 · Reply

JamesTaulman Jul. 14 at 2:47 AM

$ASND – MON: Dropped Below Its 10 DMA and Triggered a Sell Signal +5.6% 9:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/mon-7-13-asnd-dropped-below-its-10-dma-and-triggered-a-sell-signal-5-6/

0 · Reply

JamesTaulman Jul. 13 at 2:31 PM

$ASND – MON: CALLING A 1ST SELL SIGNAL @ $265.12 +5.6% 10:02 AM – Calling a 1ST SELL SIGNAL this morning as shares are breaking below the 10 DMA. That is a standard technical violation and triggers an initial SELL SIGNAL under our rules. ULTRA Trader’s Tip: The 10 DMA Provides an Early Warning • Strong stocks often use the 10 DMA as support during healthy advances. • A clear break below that line signals weakening short-term momentum. • Taking partial profits on the initial violation helps protect gains while leaving room for the stock to recover. https://buyingbreakouts.com/mon-7-13-asnd-calling-a-1st-sell-signal-265-12-5-6/

0 · Reply

JamesTaulman Jul. 10 at 3:27 AM

$ASND – THU: Posts Amid Negative Reversal – Watching the 10 DMA at $268.25 10:00 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/thu-7-9-asnd-posts-amid-negative-reversal-watching-the-10-dma-at-268-25/

0 · Reply

Night_Owl_Biotech Jul. 9 at 11:25 PM

This is an update to our $ACAD v $PTCT post from a few weeks ago. Both have gained 20-25% since 6/10/26 when the $XBI began its recent surge. Analysts project ACAD to slightly outsell PTCT over the next 5 & 10 years. Both generate the same gross margins yet ACAD's market cap & enterprise value are roughly half of PTCT. The objective of this post is to ID the disconnect between the 2. This is not to bash PTCT (which incidentally trades at lower multiples than peers with more recent approvals like $INSM & $ASND ). We'd genuinely appreciate a PTCT perspective. We added analyst EPS estimates & related multiples that identify the same disconnect in valuation. Genuine feedback would be sincerely appreciated. This is not investment advice.

2 · Reply

JamesTaulman Jul. 9 at 3:05 AM

$ASND – WED: Posts Gains From the 10 DMA to a New High Close per Volume Only Average 9:15 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/wed-7-8-asnd-posts-gains-from-the-10-dma-to-a-new-high-close-per-volume-only-average/

0 · Reply

JamesTaulman Jul. 8 at 3:40 AM

$ASND – TUE: Closed Off of the Day Highs Yet Remains Above Support of the 10 DMA 10:15 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List. https://buyingbreakouts.com/tue-7-7-asnd-closed-off-of-the-day-highs-yet-remains-above-support-of-the-10-dma/

0 · Reply

Buysidetrader69 Jul. 7 at 5:32 PM

$BCRX WEDBUSH has a $21 price tgt on $BCRX They made comments earlier that $ASND and $BCRX are ripe to be bought

0 · Reply

JFDI Jul. 7 at 3:49 PM

$ASND pretty

0 · Reply

techj2022 Jul. 7 at 3:15 PM

$ASND has to worth a lot more if $CRNX is worth 10B. ASND already profitable and revenue forecasted for next year 10x CRNX.

0 · Reply

14 value stocks of companies primed for rapid growth through 2028

ASND BILL BX CG FIGR GWRE HUBS

Jun 30, 2026, 8:30 AM EDT - 14 days ago

Market Cap	16.54B
Revenue (ttm)	814.76M
Net Income (ttm)	-258.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	58.41
Profit Margin	-31.67%
Debt to Equity Ratio	1.84

Volume	516,500
Avg Vol	736,204
Day's Range	N/A - N/A
Shares Out	62.38M
Stochastic %K	18%
Beta	0.37
Analysts	Strong Sell
Price Target	$301.56